Inventor · disambiguated record
David Flyer
Also filed as: FLYER DAVID · FLYER DAVID C
10 granted patents·3 pending applications·97 citations·filing 1997–2025
88Inventor score
Top patents by PatentIndex Score
13 records- 0194US10357557B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2017·Granted Jul 23, 2019·13 cites·15 claims
- 0290US10821166B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2019·Granted Nov 3, 2020·3 cites·18 claims
- 0387US11478540B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2021·Granted Oct 25, 2022·1 cites·12 claims
- 0484US2025360191A1Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2025·Application pending·0 cites
- 0583US12324831B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2022·Granted Jun 10, 2025·0 cites·19 claims
- 0683US6890753B2Modified rapid expansion methods(“modified-REM”) for in vitro propagation of T lymphocytesFiled 2001·Granted May 10, 2005·17 cites·31 claims
- 0782US11123419B2Methods and compositions for inducing immune responses against Clostridium difficileNOVAVAX INC·Filed 2018·Granted Sep 21, 2021·1 cites·22 claims
- 0882US6316257B1Modified rapid expansion methods (“modified-REM”) for in vitro propagation of T lymphocytesTARGETED GENETICS CORP·Filed 1997·Granted Nov 13, 2001·57 cites·26 claims
- 0980US9598472B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofELLINGSWORTH LARRY R·Filed 2011·Granted Mar 21, 2017·5 cites·8 claims
- 1073US11357844B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2020·Granted Jun 14, 2022·0 cites·20 claims
- 1170US11938179B2Methods and compositions for inducing immune responses against Clostridium difficileNOVAVAX INC·Filed 2021·Granted Mar 26, 2024·0 cites·20 claims
- 1251US2005164387A1Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytesTARGETED GENETICS CORP·Filed 2005·Application pending·0 cites
- 1344US2002192229A1MHC class I associated peptides for prevention and treatment of tuberculosisFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →